APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tacrolimus

Compare research editions
View pricing & licenses

Selected research

Industry Research

Tacrolimus Industry Research Report 2026

20 December 2025142 pages

Choose your research edition.

Industry ResearchTacrolimus Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Tacrolimus Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Tacrolimus Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tacrolimus Market Outlook and Growth Opportunities 2026217 pages · $4,250 USDMarket Analysis & ForecastGlobal Tacrolimus Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

The global Tacrolimus market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Tacrolimus is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Tacrolimus is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Tacrolimus is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Tacrolimus include GSK, Abbott, Takeda, Sichuan Med-Shine Pharmaceutical, Sandoz, Novartis, Mylan, Zhongmei Huadong Pharmaceutical and Hisun Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Tacrolimus market in terms of revenue (US$ million) and, where applicable, sales volume (K Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Tons) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Tacrolimus Market by Company

GSK

Abbott

Takeda

Sichuan Med-Shine Pharmaceutical

Sandoz

Novartis

Mylan

Zhongmei Huadong Pharmaceutical

Hisun Pharmaceutical

Yamanouchi Pharmaceutical

Tecoland

Suzhou Pharmaceutical Technology

Squibb

Sinopharm Chuankang Pharmaceutical

Senju Pharmaceutical

ScinoPharm

RPG Life Science

Roche Pharma

Huapont Pharma

Guike Pharmaceutical

Fujisawa Pharmaceutical

Astellas

Accura Pharmaceuticals

Aarti Group

Tacrolimus Segment by Type

Tacrolimus Capsules

Tacrolimus Ointment

Tacrolimus Injection

Tacrolimus Segment by Application

Hospitals

Clinics

Other

Tacrolimus Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tacrolimus market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tacrolimus and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tacrolimus.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Tacrolimus manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Tacrolimus by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Tacrolimus in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Tacrolimus Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Tacrolimus Sales (K Tons) of Manufacturers (2021-2026) Table 7. Global Tacrolimus Sales Market Share by Manufacturers (2021-2026) Table 8. Global Tacrolimus Revenue of Manufacturers (2021-2026) Table 9. Global Tacrolimus Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Tacrolimus Average Price (US$/Ton) of Manufacturers (2021-2026) Table 11. Global Tacrolimus Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Tacrolimus, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Tacrolimus, Product Type & Application Table 14. Global Tacrolimus Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Tacrolimus by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. GSK Company Information Table 19. GSK Business Overview Table 20. GSK Tacrolimus Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 21. GSK Tacrolimus Product Portfolio Table 22. GSK Recent Developments Table 23. Abbott Company Information Table 24. Abbott Business Overview Table 25. Abbott Tacrolimus Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 26. Abbott Tacrolimus Product Portfolio Table 27. Abbott Recent Developments Table 28. Takeda Company Information Table 29. Takeda Business Overview Table 30. Takeda Tacrolimus Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 31. Takeda Tacrolimus Product Portfolio Table 32. Takeda Recent Developments Table 33. Sichuan Med-Shine Pharmaceutical Company Information Table 34. Sichuan Med-Shine Pharmaceutical Business Overview Table 35. Sichuan Med-Shine Pharmaceutical Tacrolimus Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 36. Sichuan Med-Shine Pharmaceutical Tacrolimus Product Portfolio Table 37. Sichuan Med-Shine Pharmaceutical Recent Developments Table 38. Sandoz Company Information Table 39. Sandoz Business Overview Table 40. Sandoz Tacrolimus Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 41. Sandoz Tacrolimus Product Portfolio Table 42. Sandoz Recent Developments Table 43. Novartis Company Information Table 44. Novartis Business Overview Table 45. Novartis Tacrolimus Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 46. Novartis Tacrolimus Product Portfolio Table 47. Novartis Recent Developments Table 48. Mylan Company Information Table 49. Mylan Business Overview Table 50. Mylan Tacrolimus Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 51. Mylan Tacrolimus Product Portfolio Table 52. Mylan Recent Developments Table 53. Zhongmei Huadong Pharmaceutical Company Information Table 54. Zhongmei Huadong Pharmaceutical Business Overview Table 55. Zhongmei Huadong Pharmaceutical Tacrolimus Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 56. Zhongmei Huadong Pharmaceutical Tacrolimus Product Portfolio Table 57. Zhongmei Huadong Pharmaceutical Recent Developments Table 58. Hisun Pharmaceutical Company Information Table 59. Hisun Pharmaceutical Business Overview Table 60. Hisun Pharmaceutical Tacrolimus Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 61. Hisun Pharmaceutical Tacrolimus Product Portfolio Table 62. Hisun Pharmaceutical Recent Developments Table 63. Yamanouchi Pharmaceutical Company Information Table 64. Yamanouchi Pharmaceutical Business Overview Table 65. Yamanouchi Pharmaceutical Tacrolimus Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 66. Yamanouchi Pharmaceutical Tacrolimus Product Portfolio Table 67. Yamanouchi Pharmaceutical Recent Developments Table 68. Tecoland Company Information Table 69. Tecoland Business Overview Table 70. Tecoland Tacrolimus Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 71. Tecoland Tacrolimus Product Portfolio Table 72. Tecoland Recent Developments Table 73. Suzhou Pharmaceutical Technology Company Information Table 74. Suzhou Pharmaceutical Technology Business Overview Table 75. Suzhou Pharmaceutical Technology Tacrolimus Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 76. Suzhou Pharmaceutical Technology Tacrolimus Product Portfolio Table 77. Suzhou Pharmaceutical Technology Recent Developments Table 78. Squibb Company Information Table 79. Squibb Business Overview Table 80. Squibb Tacrolimus Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 81. Squibb Tacrolimus Product Portfolio Table 82. Squibb Recent Developments Table 83. Sinopharm Chuankang Pharmaceutical Company Information Table 84. Sinopharm Chuankang Pharmaceutical Business Overview Table 85. Sinopharm Chuankang Pharmaceutical Tacrolimus Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 86. Sinopharm Chuankang Pharmaceutical Tacrolimus Product Portfolio Table 87. Sinopharm Chuankang Pharmaceutical Recent Developments Table 88. Senju Pharmaceutical Company Information Table 89. Senju Pharmaceutical Business Overview Table 90. Senju Pharmaceutical Tacrolimus Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 91. Senju Pharmaceutical Tacrolimus Product Portfolio Table 92. Senju Pharmaceutical Recent Developments Table 93. ScinoPharm Company Information Table 94. ScinoPharm Business Overview Table 95. ScinoPharm Tacrolimus Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 96. ScinoPharm Tacrolimus Product Portfolio Table 97. ScinoPharm Recent Developments Table 98. RPG Life Science Company Information Table 99. RPG Life Science Business Overview Table 100. RPG Life Science Tacrolimus Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 101. RPG Life Science Tacrolimus Product Portfolio Table 102. RPG Life Science Recent Developments Table 103. Roche Pharma Company Information Table 104. Roche Pharma Business Overview Table 105. Roche Pharma Tacrolimus Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 106. Roche Pharma Tacrolimus Product Portfolio Table 107. Roche Pharma Recent Developments Table 108. Huapont Pharma Company Information Table 109. Huapont Pharma Business Overview Table 110. Huapont Pharma Tacrolimus Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 111. Huapont Pharma Tacrolimus Product Portfolio Table 112. Huapont Pharma Recent Developments Table 113. Guike Pharmaceutical Company Information Table 114. Guike Pharmaceutical Business Overview Table 115. Guike Pharmaceutical Tacrolimus Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 116. Guike Pharmaceutical Tacrolimus Product Portfolio Table 117. Guike Pharmaceutical Recent Developments Table 118. Fujisawa Pharmaceutical Company Information Table 119. Fujisawa Pharmaceutical Business Overview Table 120. Fujisawa Pharmaceutical Tacrolimus Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 121. Fujisawa Pharmaceutical Tacrolimus Product Portfolio Table 122. Fujisawa Pharmaceutical Recent Developments Table 123. Astellas Company Information Table 124. Astellas Business Overview Table 125. Astellas Tacrolimus Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 126. Astellas Tacrolimus Product Portfolio Table 127. Astellas Recent Developments Table 128. Accura Pharmaceuticals Company Information Table 129. Accura Pharmaceuticals Business Overview Table 130. Accura Pharmaceuticals Tacrolimus Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 131. Accura Pharmaceuticals Tacrolimus Product Portfolio Table 132. Accura Pharmaceuticals Recent Developments Table 133. Aarti Group Company Information Table 134. Aarti Group Business Overview Table 135. Aarti Group Tacrolimus Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 136. Aarti Group Tacrolimus Product Portfolio Table 137. Aarti Group Recent Developments Table 138. Global Tacrolimus Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 139. Global Tacrolimus Sales by Region (2021-2026) & (K Tons) Table 140. Global Tacrolimus Sales Market Share by Region (2021-2026) Table 141. Global Tacrolimus Sales by Region (2027-2032) & (K Tons) Table 142. Global Tacrolimus Sales Market Share by Region (2027-2032) Table 143. Global Tacrolimus Revenue by Region (2021-2026) & (US$ Million) Table 144. Global Tacrolimus Revenue Market Share by Region (2021-2026) Table 145. Global Tacrolimus Revenue by Region (2027-2032) & (US$ Million) Table 146. Global Tacrolimus Revenue Market Share by Region (2027-2032) Table 147. North America Tacrolimus Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. North America Tacrolimus Sales by Country (2021-2026) & (K Tons) Table 149. North America Tacrolimus Sales by Country (2027-2032) & (K Tons) Table 150. North America Tacrolimus Revenue by Country (2021-2026) & (US$ Million) Table 151. North America Tacrolimus Revenue by Country (2027-2032) & (US$ Million) Table 152. Europe Tacrolimus Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 153. Europe Tacrolimus Sales by Country (2021-2026) & (K Tons) Table 154. Europe Tacrolimus Sales by Country (2027-2032) & (K Tons) Table 155. Europe Tacrolimus Revenue by Country (2021-2026) & (US$ Million) Table 156. Europe Tacrolimus Revenue by Country (2027-2032) & (US$ Million) Table 157. Asia Pacific Tacrolimus Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 158. Asia Pacific Tacrolimus Sales by Country (2021-2026) & (K Tons) Table 159. Asia Pacific Tacrolimus Sales by Country (2027-2032) & (K Tons) Table 160. Asia Pacific Tacrolimus Revenue by Country (2021-2026) & (US$ Million) Table 161. Asia Pacific Tacrolimus Revenue by Country (2027-2032) & (US$ Million) Table 162. South America Tacrolimus Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 163. South America Tacrolimus Sales by Country (2021-2026) & (K Tons) Table 164. South America Tacrolimus Sales by Country (2027-2032) & (K Tons) Table 165. South America Tacrolimus Revenue by Country (2021-2026) & (US$ Million) Table 166. South America Tacrolimus Revenue by Country (2027-2032) & (US$ Million) Table 167. Middle East and Africa Tacrolimus Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 168. Middle East and Africa Tacrolimus Sales by Country (2021-2026) & (K Tons) Table 169. Middle East and Africa Tacrolimus Sales by Country (2027-2032) & (K Tons) Table 170. Middle East and Africa Tacrolimus Revenue by Country (2021-2026) & (US$ Million) Table 171. Middle East and Africa Tacrolimus Revenue by Country (2027-2032) & (US$ Million) Table 172. Global Tacrolimus Sales by Type (2021-2026) & (K Tons) Table 173. Global Tacrolimus Sales by Type (2027-2032) & (K Tons) Table 174. Global Tacrolimus Sales Market Share by Type (2021-2026) Table 175. Global Tacrolimus Sales Market Share by Type (2027-2032) Table 176. Global Tacrolimus Revenue by Type (2021-2026) & (US$ Million) Table 177. Global Tacrolimus Revenue by Type (2027-2032) & (US$ Million) Table 178. Global Tacrolimus Revenue Market Share by Type (2021-2026) Table 179. Global Tacrolimus Revenue Market Share by Type (2027-2032) Table 180. Global Tacrolimus Price by Type (2021-2026) & (US$/Ton) Table 181. Global Tacrolimus Price by Type (2027-2032) & (US$/Ton) Table 182. Global Tacrolimus Sales by Application (2021-2026) & (K Tons) Table 183. Global Tacrolimus Sales by Application (2027-2032) & (K Tons) Table 184. Global Tacrolimus Sales Market Share by Application (2021-2026) Table 185. Global Tacrolimus Sales Market Share by Application (2027-2032) Table 186. Global Tacrolimus Revenue by Application (2021-2026) & (US$ Million) Table 187. Global Tacrolimus Revenue by Application (2027-2032) & (US$ Million) Table 188. Global Tacrolimus Revenue Market Share by Application (2021-2026) Table 189. Global Tacrolimus Revenue Market Share by Application (2027-2032) Table 190. Global Tacrolimus Price by Application (2021-2026) & (US$/Ton) Table 191. Global Tacrolimus Price by Application (2027-2032) & (US$/Ton) Table 192. Key Raw Materials Table 193. Raw Materials Key Suppliers Table 194. Tacrolimus Distributors List Table 195. Tacrolimus Customers List Table 196. Tacrolimus Industry Trends Table 197. Tacrolimus Industry Drivers Table 198. Tacrolimus Industry Restraints Table 199. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Tacrolimus Product Image Figure 5. Global Tacrolimus Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Tacrolimus Market Size (2021-2032) & (US$ Million) Figure 7. Global Tacrolimus Sales (2021-2032) & (K Tons) Figure 8. Global Tacrolimus Average Price (US$/Ton) & (2021-2032) Figure 9. Tacrolimus Capsules Product Image Figure 10. Tacrolimus Ointment Product Image Figure 11. Tacrolimus Injection Product Image Figure 12. Hospitals Product Image Figure 13. Clinics Product Image Figure 14. Other Product Image Figure 15. Global Tacrolimus Revenue Share by Manufacturers in 2025 Figure 16. Global Manufacturers of Tacrolimus, Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 Tacrolimus Players Market Share by Revenue in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Tacrolimus Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 20. Global Tacrolimus Sales by Region in 2025 Figure 21. Global Tacrolimus Revenue by Region in 2025 Figure 22. North America Tacrolimus Market Size by Country in 2025 Figure 23. North America Tacrolimus Sales Market Share by Country (2021-2032) Figure 24. North America Tacrolimus Revenue Market Share by Country (2021-2032) Figure 25. United States Tacrolimus Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Canada Tacrolimus Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Tacrolimus Market Size by Country in 2025 Figure 28. Europe Tacrolimus Sales Market Share by Country (2021-2032) Figure 29. Europe Tacrolimus Revenue Market Share by Country (2021-2032) Figure 30. Germany Tacrolimus Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Tacrolimus Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Tacrolimus Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Tacrolimus Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Netherlands Tacrolimus Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Asia Pacific Tacrolimus Market Size by Country in 2025 Figure 36. Asia Pacific Tacrolimus Sales Market Share by Country (2021-2032) Figure 37. Asia Pacific Tacrolimus Revenue Market Share by Country (2021-2032) Figure 38. China Tacrolimus Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Japan Tacrolimus Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. South Korea Tacrolimus Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. India Tacrolimus Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Australia Tacrolimus Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. China Taiwan Tacrolimus Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Southeast Asia Tacrolimus Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Southeast Asia Tacrolimus Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. South America Tacrolimus Market Size by Country in 2025 Figure 47. South America Tacrolimus Sales Market Share by Country (2021-2032) Figure 48. South America Tacrolimus Revenue Market Share by Country (2021-2032) Figure 49. Mexico Tacrolimus Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Brazil Tacrolimus Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Argentina Tacrolimus Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Middle East and Africa Tacrolimus Market Size by Country in 2025 Figure 53. Middle East and Africa Tacrolimus Sales Market Share by Country (2021-2032) Figure 54. Middle East and Africa Tacrolimus Revenue Market Share by Country (2021-2032) Figure 55. Turkey Tacrolimus Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Saudi Arabia Tacrolimus Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. UAE Tacrolimus Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Global Tacrolimus Sales Market Share by Type (2021-2032) Figure 59. Global Tacrolimus Revenue Market Share by Type (2021-2032) Figure 60. Global Tacrolimus Price (US$/Ton) by Type (2021-2032) Figure 61. Global Tacrolimus Sales Market Share by Application (2021-2032) Figure 62. Global Tacrolimus Revenue Market Share by Application (2021-2032) Figure 63. Global Tacrolimus Price (US$/Ton) by Application (2021-2032) Figure 64. Tacrolimus Value Chain Figure 65. Tacrolimus Production Mode & Process Figure 66. Direct Comparison with Distribution Share Figure 67. Distributors Profiles Figure 68. Tacrolimus Industry Opportunities and Challenges

Scope & coverage.

Types
  • Tacrolimus Capsules
  • Tacrolimus Ointment
  • Tacrolimus Injection
Applications
  • Hospitals
  • Clinics
  • Other
Companies covered
  • GSK
  • Abbott
  • Takeda
  • Sichuan Med-Shine Pharmaceutical
  • Sandoz
  • Novartis
  • Mylan
  • Zhongmei Huadong Pharmaceutical
  • Hisun Pharmaceutical
  • Yamanouchi Pharmaceutical
  • Tecoland
  • Suzhou Pharmaceutical Technology
  • Squibb
  • Sinopharm Chuankang Pharmaceutical
  • Senju Pharmaceutical
  • ScinoPharm
  • RPG Life Science
  • Roche Pharma
  • Huapont Pharma
  • Guike Pharmaceutical
  • Fujisawa Pharmaceutical
  • Astellas
  • Accura Pharmaceuticals
  • Aarti Group

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Tacrolimus Market Size (2021-2032)
  4. 2.2.2 Global Tacrolimus Sales (2021-2032)
  5. 2.2.3 Global Tacrolimus Market Average Price (2021-2032)
  6. 2.3 Tacrolimus by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Tacrolimus Capsules
  9. 2.3.3 Tacrolimus Ointment
  10. 2.3.4 Tacrolimus Injection
  11. 2.4 Tacrolimus by Application
  12. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  13. 2.4.2 Hospitals
  14. 2.4.3 Clinics
  15. 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Tacrolimus Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Tacrolimus Sales (K Tons) of Manufacturers (2021-2026)
  3. 3.3 Global Tacrolimus Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Tacrolimus Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Tacrolimus Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Tacrolimus, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Tacrolimus, Product Type & Application
  8. 3.8 Global Manufacturers of Tacrolimus, Established Date
  9. 3.9 Global Tacrolimus Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 GSK
  2. 4.1.1 GSK Company Information
  3. 4.1.2 GSK Business Overview
  4. 4.1.3 GSK Tacrolimus Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 GSK Tacrolimus Product Portfolio
  6. 4.1.5 GSK Recent Developments
  7. 4.2 Abbott
  8. 4.2.1 Abbott Company Information
  9. 4.2.2 Abbott Business Overview
  10. 4.2.3 Abbott Tacrolimus Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Abbott Tacrolimus Product Portfolio
  12. 4.2.5 Abbott Recent Developments
  13. 4.3 Takeda
  14. 4.3.1 Takeda Company Information
  15. 4.3.2 Takeda Business Overview
  16. 4.3.3 Takeda Tacrolimus Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Takeda Tacrolimus Product Portfolio
  18. 4.3.5 Takeda Recent Developments
  19. 4.4 Sichuan Med-Shine Pharmaceutical
  20. 4.4.1 Sichuan Med-Shine Pharmaceutical Company Information
  21. 4.4.2 Sichuan Med-Shine Pharmaceutical Business Overview
  22. 4.4.3 Sichuan Med-Shine Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Sichuan Med-Shine Pharmaceutical Tacrolimus Product Portfolio
  24. 4.4.5 Sichuan Med-Shine Pharmaceutical Recent Developments
  25. 4.5 Sandoz
  26. 4.5.1 Sandoz Company Information
  27. 4.5.2 Sandoz Business Overview
  28. 4.5.3 Sandoz Tacrolimus Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Sandoz Tacrolimus Product Portfolio
  30. 4.5.5 Sandoz Recent Developments
  31. 4.6 Novartis
  32. 4.6.1 Novartis Company Information
  33. 4.6.2 Novartis Business Overview
  34. 4.6.3 Novartis Tacrolimus Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Novartis Tacrolimus Product Portfolio
  36. 4.6.5 Novartis Recent Developments
  37. 4.7 Mylan
  38. 4.7.1 Mylan Company Information
  39. 4.7.2 Mylan Business Overview
  40. 4.7.3 Mylan Tacrolimus Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Mylan Tacrolimus Product Portfolio
  42. 4.7.5 Mylan Recent Developments
  43. 4.8 Zhongmei Huadong Pharmaceutical
  44. 4.8.1 Zhongmei Huadong Pharmaceutical Company Information
  45. 4.8.2 Zhongmei Huadong Pharmaceutical Business Overview
  46. 4.8.3 Zhongmei Huadong Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Zhongmei Huadong Pharmaceutical Tacrolimus Product Portfolio
  48. 4.8.5 Zhongmei Huadong Pharmaceutical Recent Developments
  49. 4.9 Hisun Pharmaceutical
  50. 4.9.1 Hisun Pharmaceutical Company Information
  51. 4.9.2 Hisun Pharmaceutical Business Overview
  52. 4.9.3 Hisun Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Hisun Pharmaceutical Tacrolimus Product Portfolio
  54. 4.9.5 Hisun Pharmaceutical Recent Developments
  55. 4.10 Yamanouchi Pharmaceutical
  56. 4.10.1 Yamanouchi Pharmaceutical Company Information
  57. 4.10.2 Yamanouchi Pharmaceutical Business Overview
  58. 4.10.3 Yamanouchi Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Yamanouchi Pharmaceutical Tacrolimus Product Portfolio
  60. 4.10.5 Yamanouchi Pharmaceutical Recent Developments
  61. 4.11 Tecoland
  62. 4.11.1 Tecoland Company Information
  63. 4.11.2 Tecoland Business Overview
  64. 4.11.3 Tecoland Tacrolimus Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Tecoland Tacrolimus Product Portfolio
  66. 4.11.5 Tecoland Recent Developments
  67. 4.12 Suzhou Pharmaceutical Technology
  68. 4.12.1 Suzhou Pharmaceutical Technology Company Information
  69. 4.12.2 Suzhou Pharmaceutical Technology Business Overview
  70. 4.12.3 Suzhou Pharmaceutical Technology Tacrolimus Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Suzhou Pharmaceutical Technology Tacrolimus Product Portfolio
  72. 4.12.5 Suzhou Pharmaceutical Technology Recent Developments
  73. 4.13 Squibb
  74. 4.13.1 Squibb Company Information
  75. 4.13.2 Squibb Business Overview
  76. 4.13.3 Squibb Tacrolimus Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Squibb Tacrolimus Product Portfolio
  78. 4.13.5 Squibb Recent Developments
  79. 4.14 Sinopharm Chuankang Pharmaceutical
  80. 4.14.1 Sinopharm Chuankang Pharmaceutical Company Information
  81. 4.14.2 Sinopharm Chuankang Pharmaceutical Business Overview
  82. 4.14.3 Sinopharm Chuankang Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Sinopharm Chuankang Pharmaceutical Tacrolimus Product Portfolio
  84. 4.14.5 Sinopharm Chuankang Pharmaceutical Recent Developments
  85. 4.15 Senju Pharmaceutical
  86. 4.15.1 Senju Pharmaceutical Company Information
  87. 4.15.2 Senju Pharmaceutical Business Overview
  88. 4.15.3 Senju Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Senju Pharmaceutical Tacrolimus Product Portfolio
  90. 4.15.5 Senju Pharmaceutical Recent Developments
  91. 4.16 ScinoPharm
  92. 4.16.1 ScinoPharm Company Information
  93. 4.16.2 ScinoPharm Business Overview
  94. 4.16.3 ScinoPharm Tacrolimus Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 ScinoPharm Tacrolimus Product Portfolio
  96. 4.16.5 ScinoPharm Recent Developments
  97. 4.17 RPG Life Science
  98. 4.17.1 RPG Life Science Company Information
  99. 4.17.2 RPG Life Science Business Overview
  100. 4.17.3 RPG Life Science Tacrolimus Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 RPG Life Science Tacrolimus Product Portfolio
  102. 4.17.5 RPG Life Science Recent Developments
  103. 4.18 Roche Pharma
  104. 4.18.1 Roche Pharma Company Information
  105. 4.18.2 Roche Pharma Business Overview
  106. 4.18.3 Roche Pharma Tacrolimus Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Roche Pharma Tacrolimus Product Portfolio
  108. 4.18.5 Roche Pharma Recent Developments
  109. 4.19 Huapont Pharma
  110. 4.19.1 Huapont Pharma Company Information
  111. 4.19.2 Huapont Pharma Business Overview
  112. 4.19.3 Huapont Pharma Tacrolimus Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Huapont Pharma Tacrolimus Product Portfolio
  114. 4.19.5 Huapont Pharma Recent Developments
  115. 4.20 Guike Pharmaceutical
  116. 4.20.1 Guike Pharmaceutical Company Information
  117. 4.20.2 Guike Pharmaceutical Business Overview
  118. 4.20.3 Guike Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Guike Pharmaceutical Tacrolimus Product Portfolio
  120. 4.20.5 Guike Pharmaceutical Recent Developments
  121. 4.21 Fujisawa Pharmaceutical
  122. 4.21.1 Fujisawa Pharmaceutical Company Information
  123. 4.21.2 Fujisawa Pharmaceutical Business Overview
  124. 4.21.3 Fujisawa Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2021-2026)
  125. 4.21.4 Fujisawa Pharmaceutical Tacrolimus Product Portfolio
  126. 4.21.5 Fujisawa Pharmaceutical Recent Developments
  127. 4.22 Astellas
  128. 4.22.1 Astellas Company Information
  129. 4.22.2 Astellas Business Overview
  130. 4.22.3 Astellas Tacrolimus Sales, Revenue and Gross Margin (2021-2026)
  131. 4.22.4 Astellas Tacrolimus Product Portfolio
  132. 4.22.5 Astellas Recent Developments
  133. 4.23 Accura Pharmaceuticals
  134. 4.23.1 Accura Pharmaceuticals Company Information
  135. 4.23.2 Accura Pharmaceuticals Business Overview
  136. 4.23.3 Accura Pharmaceuticals Tacrolimus Sales, Revenue and Gross Margin (2021-2026)
  137. 4.23.4 Accura Pharmaceuticals Tacrolimus Product Portfolio
  138. 4.23.5 Accura Pharmaceuticals Recent Developments
  139. 4.24 Aarti Group
  140. 4.24.1 Aarti Group Company Information
  141. 4.24.2 Aarti Group Business Overview
  142. 4.24.3 Aarti Group Tacrolimus Sales, Revenue and Gross Margin (2021-2026)
  143. 4.24.4 Aarti Group Tacrolimus Product Portfolio
  144. 4.24.5 Aarti Group Recent Developments
5 Global Tacrolimus Market Scenario by Region
  1. 5.1 Global Tacrolimus Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Tacrolimus Sales by Region: 2021-2032
  3. 5.2.1 Global Tacrolimus Sales by Region: 2021-2026
  4. 5.2.2 Global Tacrolimus Sales by Region: 2027-2032
  5. 5.3 Global Tacrolimus Revenue by Region: 2021-2032
  6. 5.3.1 Global Tacrolimus Revenue by Region: 2021-2026
  7. 5.3.2 Global Tacrolimus Revenue by Region: 2027-2032
  8. 5.4 North America Tacrolimus Market Facts & Figures by Country
  9. 5.4.1 North America Tacrolimus Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Tacrolimus Sales by Country (2021-2032)
  11. 5.4.3 North America Tacrolimus Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Tacrolimus Market Facts & Figures by Country
  15. 5.5.1 Europe Tacrolimus Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Tacrolimus Sales by Country (2021-2032)
  17. 5.5.3 Europe Tacrolimus Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific Tacrolimus Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific Tacrolimus Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific Tacrolimus Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific Tacrolimus Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America Tacrolimus Market Facts & Figures by Country
  35. 5.7.1 South America Tacrolimus Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America Tacrolimus Sales by Country (2021-2032)
  37. 5.7.3 South America Tacrolimus Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa Tacrolimus Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa Tacrolimus Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa Tacrolimus Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa Tacrolimus Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Tacrolimus Sales by Type (2021-2032)
  2. 6.1.1 Global Tacrolimus Sales by Type (2021-2032) & (K Tons)
  3. 6.1.2 Global Tacrolimus Sales Market Share by Type (2021-2032)
  4. 6.2 Global Tacrolimus Revenue by Type (2021-2032)
  5. 6.2.1 Global Tacrolimus Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Tacrolimus Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Tacrolimus Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Tacrolimus Sales by Application (2021-2032)
  2. 7.1.1 Global Tacrolimus Sales by Application (2021-2032) & (K Tons)
  3. 7.1.2 Global Tacrolimus Sales Market Share by Application (2021-2032)
  4. 7.2 Global Tacrolimus Revenue by Application (2021-2032)
  5. 7.2.1 Global Tacrolimus Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Tacrolimus Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Tacrolimus Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Tacrolimus Value Chain Analysis
  2. 8.1.1 Tacrolimus Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Tacrolimus Production Mode & Process
  5. 8.2 Tacrolimus Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Tacrolimus Distributors
  8. 8.2.3 Tacrolimus Customers
9 Global Tacrolimus Analyzing Market Dynamics
  1. 9.1 Tacrolimus Industry Trends
  2. 9.2 Tacrolimus Industry Drivers
  3. 9.3 Tacrolimus Industry Opportunities and Challenges
  4. 9.4 Tacrolimus Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst